Debate continues regarding the long-term clinical and hemodynamic benefit of homograft replacement of the diseased mitral valve. 
tion rate of the earlier forms of metal and plastic prostheses.' The homograft mitral valve appears to answer two of the major problems involved with these earlier valves, i.e., thromboembolism and bleeding associated with anticoagulation. Earlier reports have been conflicting as to the long-term clinical and hemodynamic value of the homograft valve. Gianelly and others4-7 showed good initial hemodynamic and clinical improvement. However, Suzuki et al. 8 recently stated that in their series all homograft valves had to be replaced within 25 months following surgery.
This review will present the results of longterm follow-up on a large series of patients who have had mitral homograft replacement Circulation, Volume XLlV, September 1971 at Stanford University Medical Center. Furthermore, it will assess specifically their clinical state, complications after valve replacement, incidence of mitral insufficiency, and significance of the mitral diastolic gradients.
Methods
A total of 120 patients have undergone homograft mitral valve replacement surgery at the Stanford University Medical Center between May 1967 and November 1970 under the direction of Dr. Norman E. Shumway. In this group, nine patients had both mitral and aortic homograft replacement and one had tricuspid, mitral, and aortic homografts. The age range of the group was 7 to 70 years (average 44 years) with a female to male ratio of 2 to 1. All patients were in class III or IV of the New York Heart Association classification and all had preoperative hemodynamic assessment by right and left heart catheterization. At surgery, the diseased mitral valve was replaced with a fresh aortic homograft valve which had been obtained and prepared under sterile conditions and mounted on a Tefloncovered titanium strut with an internal diameter of 27-29 mm.4 5 Anticoagulants were stopped 6 weeks after surgery. The patients were then routinely followed at 6-month intervals.
Thirteen of the 23 patients who have survived for more than 2 years have been restudied. These patients were all 25 to 41 months postoperative at the time of study. There were nine females and four males with an age range from 32 to 70 years. At the time of operation, two patients had mitral insufficiency secondary to ruptured chordae tendineae, six had pure mitral stenosis, and five had mixed stenosis and insufficiency due to rheumatic heart disease. Each patient had clinical evidence of homograft valve dysfunction. The other three patients have been reoperated 6 to 25 months following surgery. Two were found to have severe mitral insufficiency, one due to a paravalvular leak and the other secondary to Candida albicans endocarditis. The other patient had moderate mitral insufficiency and severe left ventricular failure and died at the time of reoperation to replace the homograft. There have been two patients with infected valves in the entire series, and one of these patients died. Thromboembolism has been proven in only one case in the entire group (see below).
Apical systolic murmurs have been heard in 30% of the patients and in most was first noted shortly after surgery.
In the 13 patients restudied, all were functionally class I or II at the time of postoperative evaluation. All had improved since surgery except that two patients (R. C. and D. D.) had noted recent increasing fatigue. There was one thromboembolic episode in this group (K. N.). There were no other complications following surgery, and many patients were asymptomatic and not receiving any cardiac medications. Nine decrease in heart size and clearing of pulmonary vascular congestion in 85% of the patients, but in several there was residual left atrial and right ventricular enlargement. Phonocardiography confirmed the murmurs and documented the two prominent components of the first heart sound heard clinically. This finding is in agreement with the recent work of Gianelly9 who stated that the first component was due to the closure of the homograft valve leaflets occurring in early systole. The origin of the second component remains unclear.
Echocardiography showed the movement of the homograft mitral valve ring and its leaflets. These movements are of normal amplitude but have a characteristic squarewave appearance as previously described.9
The rapid posterior motion of the valve leaflets corresponds with the first heart sound. (fig. 2 ). There was no clot in the left atrium. Microscopic examination showed a mild inflammatory infiltrate around the base of the valve and increased numbers of fibroblasts in the leaflets (fig. 3 ). The diastolic gradient may have been partially due to a small valve ring (27 mm) and an inaccurate measurement of pulmonary wedge pressure.
The mean resting cardiac output of the patients studied was 2.3 liters/min/m2, an increase of 10% since surgery. There was a further increase to a mean of 3.4 liters/min/m2 with exercise. This small change in cardiac output and poor exercise response for the group is partially accounted for by those patients with moderate mitral insufficiency (A. P. and D. D.), as well as those with primary left ventricular failure and normal valve function (R. C., F. C., and E. W.). The arteriovenous oxygen difference at rest for the group fell an average of 25% to 5 vol/ 100 ml and with exercise remained been employed including high-energy irradiation, freeze-drying, storage in formaldehyde or P-propiolactone, and preparation and storage in an antibiotic medium.8 14 17 18 It is now thought that several of these sterilization methods may contribute to late deterioration and calcification of the valves.. Problems with poor coaptation of the leaflets and commissure support, producing severe mitral regurgitation, have led to the introduction of a ring with struts to which the homograft is sutured prior to insertion. '3-19 The results of our whole series show that there has been satisfactory clinical improvement in patients having homograft mitral valve surgery. To date the late mortality rate has been low (one death per 255 months of patient follow-up), and the cause of death in these patients was often unrelated to homograft valve dysfunction (see fig. 1 ). In addition to the symptomatic improvement following surgery, these patients have been free from embolic complications with one exception. This is a major advantage over the other forms of prosthetic valves which have 10 to 30% reported incidence of thromboembolism within 5 years.:' 8 They have also avoided the risks associated with long-term anticoagulant therapy.
In patients restudied, hemodynamic data show that there has been a significant decrease in both pulmonary artery and left atrial pressures since surgery. There has been no major dysfunction of the homograft valve in our patients. Although small early diastolic gradients do exist across these valves, this may be related to the size of the valve ring onto which the homograft is sewn at the time of surgery.4 These diastolic gradients (3.0 mm Hg at rest and 6.0 mm Hg with exercise) are slightly less than with other forms of prosthetic valves. [1] [2] [3] To date there has been no proven organic stenosis of a homograft mitral valve.
Mitral insufficiency occurred to varying degrees in six patients and had been present since shortly after surgery in four of these. Review of left ventricular angiograms show prolapse of the valve leaflets into the left atrium just prior to left ventricular ejection in eight patients ( fig. 4) . This was associated with a trace of insufficiency in three patients. With the onset of left ventricular ejection there was further bulging of the valve leaflets into the atrium, and they remain in this position until end-systole ( fig. 5 ). At this point in most patients, there is no evidence for insufficiency of the valve. We postulate that the bulging of the leaflets into the atrium in early isovolumic ventricular contraction is related to the lack of papillary muscle support of these valves. In case D. D. there was actually prolapse of one of the leaflets resulting in severe mitral regurgitation. In addition, the central regurgitation seen in early systole may result from poor leaflet coaptation, secondary to curling of the valve leaflets, which actually improves with increasing intraventricular pressure. This would explain the lack of initial insufficiency during the ejection phase of systole in most of these patients. In certain patients with more significant mitral insufficiency, there appears to be slight retraction of the leaflets (see fig. 2 ) as shown at reoperation in case K. N. Histologic examination of this valve showed only a few inflammatory cells around the base of the valve and fibroblasts in the leaflet (see fig. 3 ), but no leaflet degeneration. This 
